US$ 20.12
glp 1 anaesthesia A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia | Journal of Anesthesia, Analgesia and Critical Care Perioperative management of patients taking
Description
But theres a tradeoff

Conclusions/interpretation Our findings do not support an increased risk of SIS when taking GLP-1RA in individuals with type 2 diabetes and obesity

Childhood obesity rates have skyrocketed over 300% since the 1970s, now affecting 21% of children

While its effective for headaches, muscle aches, and fever, its not without risks when combined with other substances
